SCHEMBL4245293

SCHEMBL4245293

Fc1ccc(C2(F)CC2)c(F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.42
CNR1 P21554 4/20 0.41
CES2 O00748 2/20 0.40
CES1 P23141 2/20 0.40
ALDH1A1 P00352 2/20 0.39
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
TDP2 O95551 1/20 0.37
IDO1 P14902 2/20 0.36
AGXT P21549 2/20 0.36
HCAR3 P49019 1/20 0.36
HCAR2 Q8TDS4 1/20 0.36
KDM1A O60341 1/20 0.35
CA3 P07451 1/20 0.34
CA6 P23280 1/20 0.34
CA5A P35218 1/20 0.34
CA9 Q16790 1/20 0.34
CA14 Q9ULX7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10653193 1.00 BACE1 (0.42) BACE1CNR1CES2CES1ALDH1A1
Hydrochloric Acid SCHEMBL14660865 0.85 HTR2C (0.39) BACE1CNR1ALDH1A1HDAC3HDAC1
SCHEMBL3119870 0.79 BACE1 (0.36) BACE1CNR1ALDH1A1HDAC3HDAC1
SCHEMBL14660769 0.78 CNR1 (0.49) BACE1CNR1CA6CA5ACA9
SCHEMBL3119906 0.77 BACE1 (0.38) BACE1CNR1ALDH1A1
SCHEMBL3122160 0.77 CNR1 (0.40) BACE1CNR1HDAC3HDAC1HDAC2
SCHEMBL9697435 0.76 BACE1 (0.41) BACE1CNR1CES2CES1ALDH1A1
SCHEMBL257533 0.76 BACE1 (0.49) BACE1CNR1ALDH1A1HDAC3HDAC1
SCHEMBL29664671 0.76 BACE1 (0.45) BACE1ALDH1A1HDAC3HDAC1HDAC2
SCHEMBL3849035 0.76 BACE1 (0.45) BACE1ALDH1A1HDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902227-B2 C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents JANSSEN PHARMACEUTICA NV. (BE) 2011-03-08 US claimed
US-20090029980-A1 C-7 Isoxazolinyl Quinolone / Naphthyridine Derivatives Useful as Antibacterial Agents JANSSEN PHARMACEUTICA N.V. (BE) 2009-01-29 US claimed
EP-0278346-A1 1-(2,4-Difluorophenyl)-1-(1-fluorocyclopropyl)-2-(1,2,4-triazol-1-yl)-ethan-1-ol BAYER AG (DE) 1988-08-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090029980-A1 C-7 Isoxazolinyl Quinolone / Naphthyridine Derivatives Useful as Antibacterial Agents CASP7, CYP3A7, NQO2 BACE1 2642/4885CNR1 1350/4885CES2 1679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.